Fig. 1.
![Fig. 1. Comparison of outcome for adult de novo AML patients with t(9; 11) and with other translocations involving band 11q23 [t(11q23)] at diagnosis. (A) Shows probability of remaining in CR, (B) shows probability of EFS, and (C) shows probability of survival for patients with t(9; 11) compared with those with t(11q23).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/90/11/10.1182_blood.v90.11.4532/3/bl_0030f1a.jpeg?Expires=1735572449&Signature=ojcuxR883CiAYPTPWA5Qe1nvynXz5eOEp2KFzCDgBgjyFwUoRhcy71jiAy3Uv8UssSYtSTcflEkxbRo8kaAT7kFFkLFj7o-L9QY1LO~JYbwdzJ0rhN52fsYatrHh928nvSpLWcNppZXNDqnbkqhaKVQFZfaMb7VKy2FiMaPK90~iPo-8CfT7VsqKgfNyUJmHxy9j9BdBGMqV~ZEPxD-UPR2l~cx0Y3Pg6GSoB0JrEx9yyHpTqUZ7eMtwbb5p7Npyf5k-iQvW2Zz8gUWrz4evipD04Q9lMpdmG8gVgcZQGEOSOXl6F~3mmFv0aQmC2nD787AQWwXzfTVXMFbTotf2yA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Comparison of outcome for adult de novo AML patients with t(9; 11) and with other translocations involving band 11q23 [t(11q23)] at diagnosis. (A) Shows probability of remaining in CR, (B) shows probability of EFS, and (C) shows probability of survival for patients with t(9; 11) compared with those with t(11q23).
